Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 3, 2010, Pages 329-334

  Hashemi, M ^a,b   Mehrabifar, H ^b   Daliri, M ^a   Ghavami, S ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adenosine deaminase; Psoriasis; Serum total antioxidant activity; Serum trypsin inhibitory capacity

Indexed keywords

ADENOSINE DEAMINASE; TRYPSIN; ANTIOXIDANT; BIOLOGICAL MARKER; TRYPSIN INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; RATING SCALE; SCHOOL CHILD; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FOLLOW UP; METABOLISM; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TRYPSIN INHIBITORS; YOUNG ADULT;

EID: 76349102114     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03416.x     Document Type: Article

References (43)

1. Nestle FO. Psoriasis. Curr Dir Autoimmun 2008 10 : 65 75.
2. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999 20 : 40 46.
3. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004 150 : 917 928. (Pubitemid 38903524)
4. Coble BI, Dahlgren C, Molin L, Stendahl O. Neutrophil function in psoriasis: effects of retinoids. Acta Derm Venereol 1987 67 : 481 490.
5. Wiedow O, Wiese F, Christophers E. Lesional elastase activity in psoriasis Diagnostic and prognostic significance. Arch Dermato Res 1995 287 : 632 635.
6. Cristalli G, Costanzi S, Lambertucci C et al. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001 21 : 105 128.
7. Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996 9 : 632 633.
8. Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJH. Serum adenosine deaminase: Isoenzyme and diagnostic application. Clin Chem 1992 38 : 1322 1326.
9. Zuckerman SH, Olson JM, Douglas SD. Adenosine deaminase activity during in vitro culture of human peripheral blood monocytes and pulmonary alveolar macrophages. Exp Cell Res 1980 129 : 281 287.
10. Johnson DA, Pannell RN, Travis J. The molecular stoichiometry of trypsin inhibition by human alpha-1-proteinase inhibitor. Biochem Biophys Res Commun 1974 57 : 584 589.
11. Hashemi M, Naderi M, Rashidi H, Ghavami S. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus. Diabetes Res Clin Pract 2007 75 : 246 248.
12. Mornex J, Chytil-Weir A, Martinet Y et al. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest 1986 77 : 1952 1961.
13. Venembre P, Boutten A, Seta N et al. Secretion of alpha1-antitrypsin by alveolar epithelial cells. FEBS Lett 1994 346 : 171 174.
14. Stockley RA, Bayley DL, Unsal I, Dowson LJ. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2002 165 : 1494 1498.
15. Spencer LT, Paone G, Krein PM et al. Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004 286 : L514 L520.
16. Aldonyte R, Jansson L, Janciauskiene S. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro. BMC Cell Biol 2004 5 : 11.
17. Janciauskiene S, Larsson S, Larsson P et al. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem Biophys Res Commun 2004 321 : 592 600.
18. Knight JA. Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci 1995 25 : 111 121.
19. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009, doi :.
20. Guisti G, Galanti B. Colorimetric method. In Bergmeyer HU eds. Methods of Enzymatic Analysis. Verlag Chemie, Weinheim, 1984 : 315 323.
21. Dietz AA, Rubinstein HM, Hodges LK. Measurment of alpha 1 antitrypsin in serum, by immunodiffusion and enzymatic assay. Clin Chem Lab Med 1974 20 : 396 399.
22. Benzie F, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measurement of "antioxidant power"; The FRAP assay. Anal Biochem 1996 239 : 70 76.
23. Woodley DT, Kim GH. Potential new insight into the pathogenesis of psoriasis. Arch Dermatol 2009 145 : 713 714.
24. Wang H, Peters T, Sindrilaru A et al. TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J Clin Invest 2008 118 : 2629 2639.
25. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992 126 : 1 9.
26. Vlcek F, Mikulikova D. The effect of methotrexate on activity of T-lymphocyte marker enzymes in patients with psoriasis vulgaris. Bratisl Lek Listy 1995 96 : 137 140.
27. Kose K, Utas S, Yazici C et al. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. Br J Dermatol 2001 144 : 1121 1126.
28. Iizuka H, Koizumi H, Kimura T, Miura Y. Adenosine deaminase activity in peripheral lymphocytes of psoriasis and Sezary's syndrome: possible significance in T-lymphocyte dysfunction. J Dermatol 1980 7 : 165 169.
29. Koizumi H, Ohkawara A. Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia. Acta Derm Venereol 1992 72 : 410 412.
30. Braun-Falco O, Christophers E. Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch 1974 251 : 95 110.
31. Michaelsson G. Increased chemotactic activity of neutrophil leukocytes in psoriasis. Br J Dermatol 1980 103 : 351 356.
32. Sedgwick JB, Bergstresser PR, Hurd ER. Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 1980 74 : 81 84.
33. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem 1980 255 : 3931 3934.
34. Ghavami S, Hashemi M, de Serres FJ et al. Trypsin inhibitory capacity in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2007 48 : 264 269.
35. Huntington J, Read R, Carrell R. Structure of a serpinprotease complex shows inhibition by deformation. Nature 2000 407 : 923 926.
36. Eriksson S. A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 1996 110 : 237S 242S.
37. Heng MC, Moy RL, Lieberman J. alpha 1-Antitrypsin deficiency in severe psoriasis. Br J Dermatol 1985 112 : 129 133.
38. Lieberman J, Mittman C. Dynamic response of alpha1-antitrypsin variants to diethylstilbestrol. Am J Hum Genet 1973 25 : 610 617.
39. Ghavami S, Hashemi M, Shahriari HA et al. Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran. Clin Biochem 2005 38 : 425 432.
40. Kokcam I, Naziroglu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 1999 289 : 23 31.
41. Wozniak A, Drewa G, Krzyzynska-Maliniowska E et al. Oxidant-antioxidant balance in patients with psoriasis. Med Sci Monit 2007 13 : CR30 CR33.
42. Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003 17 : 34 36.
43. Baz K, Cimen MY, Kokturk A et al. Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J 2003 44 : 987 990.